BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3437623)

  • 21. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
    Coezy E; Borgna JL; Rochefort H
    Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiestrogen treatment of breast cancer: an overview.
    Pearson OH; Manni A; Arafah BM
    Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high-affinity binding site for the antioestrogens, tamoxifen and CI 628, in immature rat uterine cytosol which is distinct from the oestrogen receptor.
    Murphy LC; Sutherland RL
    J Endocrinol; 1981 Oct; 91(1):155-61. PubMed ID: 7028904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat.
    Sudo K; Monsma FJ; Katzenellenbogen BS
    Endocrinology; 1983 Feb; 112(2):425-34. PubMed ID: 6848356
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of a triphenylethylene-antiestrogen-binding site on rat serum low density lipoprotein.
    Winneker RC; Guthrie SC; Clark JH
    Endocrinology; 1983 May; 112(5):1823-7. PubMed ID: 6832070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An antiestrogen-binding protein in human tissues.
    Kon OL
    J Biol Chem; 1983 Mar; 258(5):3173-7. PubMed ID: 6826555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High affinity specific antiestrogen binding sites are concentrated in rough microsomal membranes of rat liver.
    Watts CK; Sutherland RL
    Biochem Biophys Res Commun; 1984 Apr; 120(1):109-15. PubMed ID: 6712683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical and genetic evidence for specific antiestrogen binding sites.
    Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progesterone receptors and human breast cancer.
    Clark GM; McGuire WL
    Breast Cancer Res Treat; 1983; 3(2):157-63. PubMed ID: 6351950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Res; 1976 Dec; 36(12):4595-601. PubMed ID: 1000504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of estrogen receptor assays in human breast cancer tissue.
    McGuire WL; De La Garza M; Chamness GC
    Cancer Res; 1977 Mar; 37(3):637-9. PubMed ID: 837364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor.
    Capony F; Rochefort H
    Mol Cell Endocrinol; 1978; 11(2):181-98. PubMed ID: 680340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential binding of antiestrogens by rat uterine and chick oviduct cytosol.
    Sutherland RL; Foo MS
    Biochem Biophys Res Commun; 1979 Nov; 91(1):183-91. PubMed ID: 518621
    [No Abstract]   [Full Text] [Related]  

  • 34. Tamoxifen. Use in treatment of metastatic breast cancer refractory to combination chemotherapy.
    Legha SS; Buzdar AU; Hortobagyi GN; Wiseman C; Benjamin RS; Blumenschein GR
    JAMA; 1979 Jul; 242(1):49-52. PubMed ID: 448865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen in advanced breast cancer.
    Mouridsen H; Palshof T; Patterson J; Battersby L
    Cancer Treat Rev; 1978 Sep; 5(3):131-41. PubMed ID: 365330
    [No Abstract]   [Full Text] [Related]  

  • 36. Current status of estrogen and progesterone receptors in breast cancer.
    McGuire WL; Horwitz KB; Pearson OH; Segaloff A
    Cancer; 1977 Jun; 39(6 Suppl):2934-47. PubMed ID: 326386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study on the correlation between estrogen receptor, progesterone receptor and tamoxifen binding sites in human breast cancer tissues.
    Imanaka Y; Tsuboi S; Kohno N; Saitoh Y
    Jpn J Surg; 1987 Nov; 17(6):487-92. PubMed ID: 3437623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene.
    Valavaara R; Tuominen J; Johansson R
    Cancer; 1990 Dec; 66(11):2264-9. PubMed ID: 2147123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on mechanisms of estrogen and antiestrogen action in human breast cancer.
    Horwitz KB; McGuire WL
    Recent Results Cancer Res; 1980; 71():45-58. PubMed ID: 6988916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular aspects of estrogen receptor variants in breast cancer.
    Fuqua SA; Wolf DM
    Breast Cancer Res Treat; 1995 Sep; 35(3):233-41. PubMed ID: 7579493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.